These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27603157)

  • 1. Erratum: Transcriptional Activation by NFκB Increases Perlecan/HSPG2 Expression in the Desmoplastic Prostate Tumor Microenvironment. C. R. Warren, B. J. Grindel, L. Francis, D. D. Carson and M. C. Farach-Carson.
    J Cell Biochem; 2016 Nov; 117(11):2669. PubMed ID: 27603157
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcriptional activation by NFκB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironment.
    Warren CR; Grindel BJ; Francis L; Carson DD; Farach-Carson MC
    J Cell Biochem; 2014 Jul; 115(7):1322-33. PubMed ID: 24700612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perlecan-deficient mutation impairs corneal epithelial structure.
    Inomata T; Ebihara N; Funaki T; Matsuda A; Watanabe Y; Ning L; Xu Z; Murakami A; Arikawa-Hirasawa E
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1277-84. PubMed ID: 22266517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway.
    Datta MW; Hernandez AM; Schlicht MJ; Kahler AJ; DeGueme AM; Dhir R; Shah RB; Farach-Carson C; Barrett A; Datta S
    Mol Cancer; 2006 Mar; 5():9. PubMed ID: 16507112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
    Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
    Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of HSPG2 (Perlecan) mutations in patients with Schwartz-Jampel syndrome.
    Stum M; Davoine CS; Vicart S; Guillot-Noël L; Topaloglu H; Carod-Artal FJ; Kayserili H; Hentati F; Merlini L; Urtizberea JA; Hammouda el-H; Quan PC; Fontaine B; Nicole S
    Hum Mutat; 2006 Nov; 27(11):1082-91. PubMed ID: 16927315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perlecan is essential for cartilage and cephalic development.
    Arikawa-Hirasawa E; Watanabe H; Takami H; Hassell JR; Yamada Y
    Nat Genet; 1999 Nov; 23(3):354-8. PubMed ID: 10545953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients.
    Grindel B; Li Q; Arnold R; Petros J; Zayzafoon M; Muldoon M; Stave J; Chung LW; Farach-Carson MC
    Oncotarget; 2016 Mar; 7(9):10433-47. PubMed ID: 26862737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
    Chang YT; Tseng CN; Tannenberg P; Eriksson L; Yuan K; de Jesus Perez VA; Lundberg J; Lengquist M; Botusan IR; Catrina SB; Tran PK; Hedin U; Tran-Lundmark K
    Cardiovasc Res; 2015 Jul; 107(1):20-31. PubMed ID: 25952902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan sulfate of perlecan is involved in glomerular filtration.
    Morita H; Yoshimura A; Inui K; Ideura T; Watanabe H; Wang L; Soininen R; Tryggvason K
    J Am Soc Nephrol; 2005 Jun; 16(6):1703-10. PubMed ID: 15872080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heparan sulphate deficient Hspg2 exon 3 null mouse displays reduced deposition of TGF-β1 in skin compared to C57BL/6 wild type mice.
    Shu C; Smith SM; Melrose J
    J Mol Histol; 2016 Jun; 47(3):365-74. PubMed ID: 27098652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can rs3767140 SNP of the perlecan (HSPG2) gene affect the diabetes mellitus through the dyslipidemia?
    Kurnaz-Gömleksiz Ö; Tokat B; Aslan EI; Yanar F; Ermiş-Karaali Z; Öztürk O; Yilmaz-Aydoğan H
    Cell Mol Biol (Noisy-le-grand); 2016 Jul; 62(8):35-9. PubMed ID: 27545212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum for the Report "Genomic correlates of response to CTLA-4 blockade in metastatic melanoma" by E. M. Van Allen, D. Miao, B. Schilling, S. A. Shukla, C. Blank, L. Zimmer, A. Sucker, U. Hillen, M. H. Geukes Foppen, S. M. Goldinger, J. Utikal, J. C. Hassel, B. Weide, K. C. Kaehler, C. Loquai, P. Mohr, R. Gutzmer, R. Dummer, S. Gabriel, C. J. Wu, D. Schadendorf, L. A. Garraway.
    Science; 2016 Apr; 352(6283):. PubMed ID: 27081077
    [No Abstract]   [Full Text] [Related]  

  • 14. Erratum for the Report "Genomic correlates of response to CTLA-4 blockade in metastatic melanoma" by E. M. Van Allen, D. Miao, B. Schilling, S. A. Shukla, C. Blank, L. Zimmer, A. Sucker, U. Hillen, M. H. Geukes Foppen, S. M. Goldinger, J. Utikal, J. C. Hassel, B. Weide, K. C. Kaehler, C. Loquai, P. Mohr, R. Gutzmer, R. Dummer, S. Gabriel, C. J. Wu, D. Schadendorf, L. A. Garraway.
    Science; 2015 Nov; 350(6262):aad8366. PubMed ID: 26564858
    [No Abstract]   [Full Text] [Related]  

  • 15. Transcriptional complexity of the HSPG2 gene in the human mast cell line, HMC-1.
    Lord MS; Jung M; Cheng B; Whitelock JM
    Matrix Biol; 2014 Apr; 35():123-31. PubMed ID: 24365408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.
    Qiang B; Lim SY; Lekas M; Kuliszewski MA; Wolff R; Osherov AB; Rudenko D; Leong-Poi H; Noyan H; Husain M; Tran K; Tryggvason K; Hedin U; Tran-Lundmark K; Strauss BH
    Can J Cardiol; 2014 Nov; 30(11):1444-51. PubMed ID: 25249499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum for the Research Article: "Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency" by S. S. De Ravin, X. Wu, S. Moir, S. Anaya-O'Brien, N. Kwatemaa, P. Littel, N. Theobald, U. Choi, L. Su, M. Marquesen, D. Hilligoss, J. Lee, C. M. Buckner, K. A. Zarember, G. O'Connor, D. McVicar, D. Kuhns, R. E. Throm, S. Zhou, L. D. Notarangelo, I. C. Hanson, M. J. Cowan, E. Kang, C. Hadigan, M. Meagher, J. T. Gray, B. P. Sorrentino, H. L. Malech.
    Sci Transl Med; 2016 Jun; 8(341):341er5. PubMed ID: 27252172
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
    Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
    Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.
    Arikawa-Hirasawa E; Wilcox WR; Le AH; Silverman N; Govindraj P; Hassell JR; Yamada Y
    Nat Genet; 2001 Apr; 27(4):431-4. PubMed ID: 11279527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-operative functions between nuclear factors NFkappaB and CCAT/enhancer-binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cells.
    Xiao W; Hodge DR; Wang L; Yang X; Zhang X; Farrar WL
    Prostate; 2004 Dec; 61(4):354-70. PubMed ID: 15389813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.